Over the last 12 months, Strategy insiders reported 9 buys totaling $4.6M and 39 sales totaling $32.9M across SEC Form 4 filings. 33% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Patten Jarrod MD | ▼ Sale | 475 | $171 | $81K | -1.6% | — |
| Sep 21, 2026 | Patten Jarrod MD | ▼ Sale | 1,425 | $167.33 | $238K | -4.8% | 3 tranches |
| Sep 4, 2026 | Chow Thomas C.EVP & General Counsel · O | ▼ Sale | 106 | $138.75 | $15K | -100% | — |
| Aug 27, 2026 | Patten Jarrod MD | ▼ Sale | 1,850 | $130 | $241K | -6.1% | 2 tranches |
| Aug 25, 2026 | Patten Jarrod MD | ▼ Sale | 3,700 | $124.58 | $461K | -11.5% | 4 tranches |
| Aug 7, 2026 | Patten Jarrod MD | ▼ Sale | 3,800 | $102.41 | $389K | -11.8% | 3 tranches |
| Jul 27, 2026 | Patten Jarrod MD | ▼ Sale | 3,900 | $95.47 | $372K | -12.1% | 2 tranches |
| Jul 22, 2026 | Patten Jarrod MD | ▼ Sale | 1,250 | $100 | $125K | -4.2% | — |
| Jun 23, 2026 | Patten Jarrod MD | ▼ Sale | 1,500 | $106.08 | $159K | -5% | — |
| Jun 22, 2026 | Le PhongPresident & CEO · O·D | ▲ Buy | 11,000 | $90.8 | $999K | — | indirect |
| Jun 17, 2026 | Patten Jarrod MD | ▼ Sale | 1,500 | $121.31 | $182K | -5% | — |
| Jun 16, 2026 | Chow Thomas C.EVP & General Counsel · O | ▲ Buy | 111 | $90.07 | $10K | — | 2 tranches |
| Jun 15, 2026 | Patten Jarrod MD | ▼ Sale | 1,500 | $133.97 | $201K | -5% | — |
| Jun 9, 2026 | Le PhongPresident & CEO · O·D | ▼ Sale | 5,522 | $123.84 | $684K | -4.2% | plan · 3 tranches |
| Jun 9, 2026 | Kang AndrewEVP & CFO · O | ▼ Sale | 1,949 | $123.84 | $241K | -2.7% | plan · 3 tranches |
| Jun 9, 2026 | Montgomery JeanineVP & CAO · O | ▼ Sale | 354 | $123.84 | $44K | -3.1% | plan · 3 tranches |
| Jun 5, 2026 | Kang AndrewEVP & CFO · O | ▼ Sale | 33,062 | $118.73 | $3.9M | -32.5% | plan · 12 tranches |
| Jun 5, 2026 | Le PhongPresident & CEO · O·D | ▼ Sale | 93,738 | $118.73 | $11.1M | -43.9% | plan · 12 tranches |
| May 29, 2026 | Patten Jarrod MD | ▼ Sale | 22,300 | $152.6 | $3.4M | -44.3% | 11 tranches |
| May 26, 2026 | Patten Jarrod MD | ▼ Sale | 1,250 | $165.3 | $207K | -4.3% | — |
| May 22, 2026 | Le PhongPresident & CEO · O·D | ▲ Buy | 50 | $99.41 | $5K | +70.4% | indirect |
| May 4, 2026 | Patten Jarrod MD | ▼ Sale | 2,000 | $183.25 | $367K | -6.7% | 4 tranches |
| May 1, 2026 | Patten Jarrod MD | ▼ Sale | 4,000 | $169.18 | $677K | -12.5% | 7 tranches |
| Apr 22, 2026 | Patten Jarrod MD | ▼ Sale | 2,000 | $178.16 | $356K | -6.7% | 4 tranches |
| Apr 21, 2026 | Patten Jarrod MD | ▼ Sale | 2,000 | $168.21 | $336K | -6.7% | 3 tranches |
| Apr 13, 2026 | Patten Jarrod MD | ▼ Sale | 3,400 | $130.64 | $444K | -10.8% | 2 tranches |
| Apr 9, 2026 | Patten Jarrod MD | ▼ Sale | 1,900 | $130.58 | $248K | -6.4% | 2 tranches |
| Apr 8, 2026 | Patten Jarrod MD | ▼ Sale | 2,100 | $128.88 | $271K | -7% | 2 tranches |
| Apr 1, 2026 | Patten Jarrod MD | ▼ Sale | 1,400 | $123.32 | $173K | -4.8% | 2 tranches |
| Mar 30, 2026 | Patten Jarrod MD | ▼ Sale | 700 | $128.04 | $90K | -2.4% | — |
| Mar 26, 2026 | Patten Jarrod MD | ▼ Sale | 700 | $137.37 | $96K | -2.4% | — |
| Mar 24, 2026 | Montgomery JeanineVP & CAO · O | ▼ Sale | 470 | $138.33 | $65K | -4.3% | plan · 3 tranches |
| Mar 24, 2026 | Kang AndrewEVP & CFO · O | ▼ Sale | 2,373 | $138.33 | $328K | -8.1% | plan · 3 tranches |
| Mar 24, 2026 | Le PhongPresident & CEO · O·D | ▼ Sale | 3,299 | $138.33 | $456K | -12.6% | plan · 3 tranches |
| Mar 19, 2026 | Le PhongPresident & CEO · O·D | ▲ Buy | 2,509 | $99.62 | $250K | +45.6% | — |
| Mar 12, 2026 | Montgomery JeanineVP & CAO · O | ▼ Sale | 260 | $137.25 | $36K | -2.7% | plan |
| Mar 12, 2026 | Kang AndrewEVP & CFO · O | ▼ Sale | 916 | $137.25 | $126K | -3.7% | plan |
| Mar 12, 2026 | Le PhongPresident & CEO · O·D | ▼ Sale | 2,034 | $137.25 | $279K | -9.7% | plan |
| Jan 20, 2026 | Dietze Jane AD | ▲ Buy | 1,000 | $99.48 | $99K | +38.5% | — |
| Jan 12, 2026 | RICKERTSEN CARL JD | ▲ Buy | 5,000 | $155.88 | $779K | — | — |
| Jan 8, 2026 | Le PhongPresident & CEO · O·D | ▲ Buy | 12 | $99.99 | $1K | +75% | indirect |
| Nov 21, 2025 | Dietze Jane AD | ▲ Buy | 1,100 | $95.28 | $105K | +73.3% | — |
| Nov 19, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 5,200 | $201.01 | $1.0M | -13.7% | plan · 2 tranches |
| Nov 18, 2025 | Montgomery JeanineVP & CAO · O | ▼ Sale | 43 | $208.55 | $9K | -0.5% | plan |
| Nov 17, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 5,200 | $200.24 | $1.0M | -13.7% | plan · 2 tranches |
| Nov 13, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 7,934 | $225.48 | $1.8M | -19.5% | plan · 15 tranches |
| Nov 11, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 10,668 | $242.15 | $2.6M | -45.6% | plan · 5 tranches |
| Oct 17, 2025 | Patten Jarrod MD | ▲ Buy | 23,780 | $97.41 | $2.3M | +428.1% | 2 tranches |
| Oct 7, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 30,000 | $357.37 | $10.7M | -70.2% | 4 tranches |
| Sep 18, 2025 | Shao Wei-MingEVP & General Counsel · O | ▼ Sale | 10,000 | $355.79 | $3.6M | -44% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Strategy filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $STRF feed.